CEP was found to physically interact with and inhibit the Niemann–Pick disease, type C1 (NPC1) protein, leading to lysosomal cholesterol accumulation and elevated intra-lysosomal pH, which resulted in a cellular phenocopy of NPC (Table 2-H) (Lyu et al., 2017). Here, NPC1 is linked to nasopharyngeal carcinoma.